Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Concentration-effect relationships of valproic acid.

D W Chadwick

    Clinical Pharmacokinetics
    |March 1, 1985
    PubMed
    Summary

    Valproic acid is an effective anticonvulsant, but its short half-life and fluctuating levels complicate treatment. Routine monitoring is challenging due to unclear dose-related toxicity, requiring careful interpretation of serum concentrations.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    The District General Hospital as a Resource for the Provision of Neurological Services.

    Journal of the Royal College of Physicians of London·2019
    Same author

    Late-onset temporal lobe epilepsy with unilateral mesial temporal sclerosis and cognitive decline: a diagnostic dilemma.

    Seizure·2008
    Same author

    A randomised controlled trial examining the longer-term outcomes of standard versus new antiepileptic drugs. The SANAD trial.

    Health technology assessment (Winchester, England)·2007
    Same author

    Efficacy of carbamazepine and valproate as monotherapy for early epilepsy and single seizures.

    Neurology·2006
    Same author

    A meta-analysis of individual patient responses to lamotrigine or carbamazepine monotherapy.

    Neurology·2006
    Same author

    An association between type 1 diabetes and idiopathic generalized epilepsy.

    Annals of neurology·2005

    Area of Science:

    • Pharmacology
    • Clinical Neurology

    Background:

    • Valproic acid is a broad-spectrum anticonvulsant.
    • It exhibits a short half-life and significant diurnal fluctuations in serum concentrations.
    • These pharmacokinetic properties complicate the establishment of clear relationships between drug levels and clinical effects.

    Purpose of the Study:

    • To evaluate the clinical utility of routine 'one-off' serum valproate measurements.
    • To assess the challenges in correlating valproate serum concentrations with therapeutic and adverse effects.
    • To examine the established therapeutic range in light of current data.

    Main Methods:

    • Review of existing pharmacokinetic and pharmacodynamic data for valproic acid.
    • Analysis of clinical practice guidelines and literature regarding valproate monitoring.
    • Evaluation of reported adverse reactions in relation to serum concentrations.

    Main Results:

    • Difficulty in establishing clear correlations between individual serum concentrations and therapeutic or adverse effects.
    • Absence of a well-defined dose-related neurotoxicity syndrome.
    • The commonly cited therapeutic range (50-100 mg/L) requires cautious interpretation.

    Conclusions:

    • Routine 'one-off' serum valproate measurements have limited value due to pharmacokinetic variability.
    • Adverse reactions appear more frequent at concentrations exceeding 100 mg/L.
    • Clinical interpretation of valproate levels necessitates consideration of individual patient factors and fluctuating concentrations.

    Related Experiment Videos